|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/5383 | (2006.01) |
| A61K 31/7064 | (2013.01) | ||
| A61K 31/7064 | (2006.01) | ||
| A61K 31/5383 | (2013.01) | ||
| A61P 43/00 | (2006.01) | ||
| A61P 43/00 | (2018.01) | ||
| A61K 45/06 | (2013.01) | ||
| A61K 31/4985 | (2013.01) | ||
| Y02A 50/30 | (2018.01) |
| (11) | Patento numeris | 4013420 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 20764496.4 |
| Europos patento paraiškos padavimo data | 2020-08-13 | |
| (97) | Europos patento paraiškos paskelbimo data | 2022-06-22 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2023-11-01 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2020/046060 |
| Data | 2020-08-13 |
| (87) | Numeris | WO 2021/030526 |
| Data | 2021-02-18 |
| (30) | Numeris | Data | Šalis |
| 201962886806 P | 2019-08-14 | US |
| (72) |
TAYLOR, Vanessa , US
ISSAKANI, Sarkiz , US
YOUNG, Chi , US
|
| (73) |
Rigel Pharmaceuticals, Inc. ,
611 Gateway Boulevard
Suite 900, South San Francisco, CA 94080,
US
|
| (54) | METHOD OF BLOCKING OR AMELIORATING CYTOKINE RELEASE SYNDROME |
| METHOD OF BLOCKING OR AMELIORATING CYTOKINE RELEASE SYNDROME |